La Crosse Virus Nucleocapsid Antibody | 7417

La Crosse Virus Nucleocapsid Antibody | 7417 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Virus

Homology: N/A

Immunogen: La Crosse virus nucleocapsid antibody was raised against an 18 amino acid peptide near the center of the La Crosse virus nucleocapsid.
The immunogen is located within amino acids 90 - 140 of La Crosse Virus Nucleocapsid.

Research Area: Infectious Disease

Tested Application: E

Application: La Crosse virus nucleocapsid antibody can detect 10 ng La Crosse virus nucleocapsid peptide in ELISA at 1 μg/mL.

Specificiy: N/A

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: Predicted: 26 kDa

Validation: N/A

Isoform: N/A

Purification: La Crosse Virus Nucleocapsid Antibody is affinity chromatography purified via peptide column.

Clonality: Polyclonal

Clone: N/A

Isotype: IgG

Conjugate: Unconjugated

Physical State: Liquid

Buffer: La Crosse virus nucleocapsid Antibody is supplied in PBS containing 0.02% sodium azide.

Concentration: 1 mg/mL

Storage Condition: Rift Valley Fever Virus Nucleocapsid antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year.

Alternate Name: La Crosse Virus Nucleocapsid Antibody: Nucleoprotein, Nucleocapsid protein, Protein N

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: La Crosse Virus Nucleocapsid Antibody: La Crosse virus (LCV) is a single-stranded RNA virus that can cause encephalitis in humans and is transmitted predominantly by mosquitoes. It is often mistaken for herpes simplex encephalitis (1) . During human infections, LCV initially presents as a nonspecific summertime illness with fever, headache, nausea, vomiting and lethargy. Death occurs in less than 1% of clinical cases.